Stingeni, Luca, Roberto Ravasio, Chiara Palladino, Sara Di Fino, Anna Levi, Gianluca Ronci, and Paolo Gisondi. “Cost Per Responder of Upadacitinib 30 Mg and Dupilumab 300 Mg in Patients With Moderate-to-Severe Atopic Dermatitis in Italy”. Global and Regional Health Technology Assessment 12, no. 1 (March 10, 2025): 70–79. Accessed March 12, 2025. https://journals.aboutscience.eu/index.php/grhta/article/view/3458.